TradeLink Capital’s Gilead Sciences GILD Stock Holding History

TradeLink Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,680	Closed	-$283K	–	25
2020 Q2	$283K	Buy	+3,680	New	+$282K	1.18%	37
2016 Q2	–	Sell	-18,516	Closed	-$1.7M	–	113
2016 Q1	$1.7M	Buy	+18,516	New	+$1.67M	3.14%	3
2015 Q3	–	Sell	-3,743	Closed	-$438K	–	124
2015 Q2	$438K	Buy	+3,743	New	+$409K	0.65%	33
2014 Q4	–	Sell	-20	Closed	-$2K	–	439
2014 Q3	$2K	Buy	+20	New	+$1.96K	﹤0.01%	228
2013 Q4	–	Sell	-900	Closed	-$57K	–	219
2013 Q3	$57K	Buy	+900	New	+$53.8K	0.13%	176

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TradeLink Capital's GILD Position: Q3 2020 in Review

TradeLink Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,680 shares — an estimated $283K sold.

TradeLink Capital first reported a position in GILD in Q3 2013 and held it in 5 quarters. The position peaked at $1.7M in Q1 2016. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

TradeLink Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
TradeLink Capital sold 3,680 Gilead Sciences shares in Q3 2020, an estimated $283K.
TradeLink Capital first reported a position in Gilead Sciences in Q3 2013 and held it in 5 quarters.
TradeLink Capital's Gilead Sciences position peaked at $1.7M in Q1 2016.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on TradeLink Capital's 13F filing for Q3 2020, filed 2 Nov 2020.